Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.50
Delayed Data
As of May 22
 -0.04 / -0.72%
Today’s Change
3.31
Today|||52-Week Range
7.84
-27.25%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.54
Today’s open5.56
Day’s range5.42 - 5.63
Volume451,696
Average volume (3 months)955,076
Market cap$383.0M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,000.00%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio110.4
Price/Sales11.62
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
NHTCNatural Health Trend...-0.45-1.47%
XNPTXenoport Inc-0.06-0.96%
HRTXHeron Therapeutics I...-0.22-1.73%
IDRAIdera Pharmaceutical...+0.09+2.96%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers